{
    "Trade/Device Name(s)": [
        "BIOEASY Marijuana Test Dip Card",
        "BIOEASY Marijuana Test Strip"
    ],
    "Submitter Information": "Shenzhen Bioeasy Biotechnology Co., Ltd.",
    "510(k) Number": "K192301",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182530"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFW"
    ],
    "Summary Letter Date": "August 18, 2019",
    "Summary Letter Received Date": "August 23, 2019",
    "Submission Date": "September 4, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Marijuana",
        "11-nor-\u03949-THC-9-COOH",
        "11-Hydroxy-9-Tetrahydrocannabinol",
        "11-Nor-8-Tetrahydrocannabinol-9-COOH",
        "Cannabinol",
        "8-Tetrahydrocannabinol",
        "9-Tetrahydrocannabinol",
        "Cannabidiol",
        "11-Nor-9-THC-carboxy glucuronide",
        "(-)-11-nor-9-carboxy-\u0394 9-THC"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Strip",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for BIOEASY Marijuana Test Dip Card and Test Strip, lateral flow immunochromatographic assays for qualitative detection of marijuana in human urine",
    "Indications for Use Summary": "Qualitative detection of marijuana in human urine at a cutoff concentration of 50 ng/mL; provides only preliminary results, confirmatory testing by GC/MS or LC/MS recommended; for in vitro diagnostic use only",
    "fda_folder": "Toxicology"
}